
- Industry news
Industry news
- Category news
Category news
- Reports
- Key trends
- Multimedia
- Journal
- Events
- Suppliers
- Home
- Industry news
Industry news
- Category news
Category news
- Reports
- Key trends
- Multimedia
- Events
- Suppliers
NattoPharma, headquartered in Oslo, Norway, sells and develops the natural vitamin K2 product MenaQ7. The company expects to achieve a turnover of NOK80-90m in 2008.
09/07/08 Norwegian vitamin K2 products supplier NattoPharma ASA has signed a letter of intent regarding a global partnership agreement with the Danish food ingredients group Danisco A/S. The proposed agreement relates to NattoPharma's vitamin K2 products brand MenaQ7.
NattoPharma, headquartered in Oslo, Norway, sells and develops the natural vitamin K2 product MenaQ7. The company expects to achieve a turnover of NOK80-90m in 2008.
MenaQ7 provides Natural Vitamin K2 as an extract of natto, a fermented soy food from Japan. Natto is particularly rich in the highly bio-available form of vitamin K2 called menaquinone-7 (MK-7). MenaQ7 provides the only commercially available Natural Vitamin K2 with guaranteed actives and stability, clinical substantiation and international patents awarded and pending.
Upcoming webinars

The new math of functional eating in the GLP-1 era: addressing texture, nutrients, and health
Jungbunzlauer

The No-Compromise Formula: Ensuring Superior Taste in Nutrition-Focused Formulations
Biospringer by Lesaffre

All about Cococa Butter Equivalents
AAK









